Cargando…

Height and nigral neuron density in Parkinson’s disease

BACKGROUND: The dopaminergic system modulates growth hormone secretion and previous results have suggested a link between short stature and an increased risk of Parkinson’s disease (PD). METHODS: In 36 Lewy body spectrum disease (LBD) cases (PD = 22) and 19 controls, nigral TH-positive neuron densit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saari, Laura, Backman, Emmilotta A., Wahlsten, Pia, Gardberg, Maria, Kaasinen, Valtteri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277822/ https://www.ncbi.nlm.nih.gov/pubmed/35820861 http://dx.doi.org/10.1186/s12883-022-02775-2

Ejemplares similares

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

Reversing Parkinson Disease Model with in situ Converted Nigral Neurons
por: Qian, Hao, et al.
Publicado: (2020)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease
por: Simunovic, Filip, et al.
Publicado: (2010)

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene
por: Labandeira‐Garcia, Jose L., et al.
Publicado: (2022)

Parallel Appearance of Compulsive Behaviors and Artistic Creativity in Parkinson's Disease
por: Joutsa, Juho, et al.
Publicado: (2012)

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
por: Ayton, Scott, et al.
Publicado: (2014)

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson’s disease
por: Pflug, Christina, et al.
Publicado: (2020)

Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease
por: Chalazonitis, Alcmène, et al.
Publicado: (2022)

The Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice
por: Dong, Qiaoyun, et al.
Publicado: (2015)

Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson’s Disease
por: Scholten, Marlieke, et al.
Publicado: (2017)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Nigral volume loss in prodromal, early, and moderate Parkinson’s disease
por: Langley, Jason, et al.
Publicado: (2023)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson’s disease
por: Hernadi, Gabriella, et al.
Publicado: (2021)

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
por: Sian-Hulsmann, Jeswinder, et al.
Publicado: (2021)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s disease
por: Langley, Jason, et al.
Publicado: (2021)

Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
por: Jellen, Leslie C., et al.
Publicado: (2021)

Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson’s Disease
por: Wang, Qun, et al.
Publicado: (2022)

Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation
por: Martikainen, Mika H., et al.
Publicado: (2015)

Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
por: Schröter, Nils, et al.
Publicado: (2022)

Comparison of Shod and Unshod Gait in Patients With Parkinson's Disease With Subthalamic and Nigral Stimulation
por: Horn, Martin A., et al.
Publicado: (2022)

Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
por: Liu, Zhenhua, et al.
Publicado: (2022)

Serum Uric Acid and Nigral Iron Deposition in Parkinson’s Disease: A Pilot Study
por: Kim, Tae-Hyoung, et al.
Publicado: (2014)

Akinetic Crisis in Parkinson's Disease Is Associated with a Severe Loss of Striatal Dopamine Transporter Function: A Report of Two Cases
por: Kaasinen, Valtteri, et al.
Publicado: (2014)

Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal
por: Subrahmanian, Nitya, et al.
Publicado: (2021)

Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks
por: Wen, Jiaqi, et al.
Publicado: (2022)

Subthalamic and nigral neurons are differentially modulated during parkinsonian gait
por: Gulberti, Alessandro, et al.
Publicado: (2023)

Novel Pattern of Iron Deposition in the Fascicula Nigrale in Patients with Parkinson's Disease: A Pilot Study
por: Peckham, Miriam E., et al.
Publicado: (2016)

Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?
por: Railo, Henry, et al.
Publicado: (2018)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
por: Yu, Zhongyuan, et al.
Publicado: (2018)

Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration
por: Ayton, Scott, et al.
Publicado: (2014)

Deep brain stimulation for monogenic Parkinson’s disease: a systematic review
por: Kuusimäki, Tomi, et al.
Publicado: (2019)

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
por: Benner, Eric J., et al.
Publicado: (2008)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
por: Fabricius, Katrine, et al.
Publicado: (2017)

Asymmetrical nigral iron accumulation in Parkinson’s disease with motor asymmetry: an explorative, longitudinal and test-retest study
por: Guan, Xiaojun, et al.
Publicado: (2020)

Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial
por: Weiss, Daniel, et al.
Publicado: (2013)

An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
por: Hua, Ye, et al.
Publicado: (2023)

Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review
por: Boonstra, Jackson Tyler, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aio06t1op1tmr2vhlfth27bv2m